Bioton S.A. Total Assets

Latest as of December 2025: zł764.56 Million PLN ≈ $210.42 Million USD

Bioton S.A. total assets. Based on the latest financial reports, Bioton S.A. (BIO) holds total assets worth zł764.56 Million PLN (≈ $210.42 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Bioton S.A. for the company's overall valuation and market capitalisation.

Total Assets of Bioton S.A. (2005–2025)

Total assets of Bioton S.A. from 2005 to 2025. This chart illustrates how Bioton S.A.'s total assets have evolved over time, based on quarterly financial data. See latest Bioton S.A. stock price today for real-time trading data and today's change.

Bioton S.A. - Asset Composition Analysis

Bioton S.A. Total Assets Breakdown (December 2025)

Bioton S.A. total assets breakdown as of December 2025. Bioton S.A.'s total assets of zł764.56 Million consist of 19.0% current assets and 81.0% non-current assets.

Asset Category	Amount (PLN)	% of Total Assets
Cash & Equivalents	zł0.00	1.1%
Accounts Receivable	zł29.18 Million	3.8%
Inventory	zł94.91 Million	12.4%
Property, Plant & Equipment	zł0.00	0.0%
Intangible Assets	zł327.06 Million	42.8%
Goodwill	zł0.00	0.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Bioton S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Bioton S.A. short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Bioton S.A.'s current assets represent 19.0% of total assets in 2025, a decrease from 44.5% in 2005.
Cash Position: Cash and equivalents constituted 1.1% of total assets in 2025, down from 3.4% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 14.0% in 2005.
Asset Diversification: The largest asset category is intangible assets at 42.8% of total assets.

Bioton S.A. Competitors by Total Assets

Key competitors of Bioton S.A. based on total assets are shown below.

Company	Country	Total Assets
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$11.72 Billion
HLB Co. Ltd KQ:028300	Korea	₩925.44 Billion
Tubize-Fin BR:TUB	Belgium	€1.99 Billion
Shanghai Medicilon Inc SHG:688202	China	CN¥2.88 Billion
Blue Jet Healthcare Limited NSE:BLUEJET	India	Rs16.41 Billion
Hangzhou Biotest Biotech Co Ltd SHG:688767	China	CN¥2.49 Billion
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	China	CN¥725.73 Million
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	China	CN¥3.67 Billion

Bioton S.A. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.41	1.08	0.96
Quick Ratio	0.49	0.33	0.40
Cash Ratio	0.00	0.00	0.00
Working Capital	zł42.19 Million	zł10.88 Million	zł-6.06 Million

Bioton S.A. - Advanced Valuation Insights

This section examines the relationship between Bioton S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.60
Latest Market Cap to Assets Ratio	0.11
Asset Growth Rate (YoY)	-3.7%
Total Assets	zł764.56 Million
Market Capitalization	$80.35 Million USD

Valuation Analysis

Below Book Valuation: The market values Bioton S.A.'s assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Bioton S.A.'s assets decreased by 3.7% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Bioton S.A. (2005–2025)

The table below shows the annual total assets of Bioton S.A. from 2005 to 2025.

Year	Total Assets	Change
2025-12-31	zł764.56 Million ≈ $210.42 Million	-3.72%
2024-12-31	zł794.14 Million ≈ $218.56 Million	-3.42%
2023-12-31	zł822.22 Million ≈ $226.29 Million	+1.47%
2022-12-31	zł810.33 Million ≈ $223.01 Million	-6.34%
2021-12-31	zł865.19 Million ≈ $238.11 Million	-0.22%
2020-12-31	zł867.11 Million ≈ $238.64 Million	-1.62%
2019-12-31	zł881.42 Million ≈ $242.58 Million	-12.73%
2018-12-31	zł1.01 Billion ≈ $277.97 Million	-11.55%
2017-12-31	zł1.14 Billion ≈ $314.29 Million	-11.83%
2016-12-31	zł1.30 Billion ≈ $356.45 Million	+3.61%
2015-12-31	zł1.25 Billion ≈ $344.03 Million	-36.02%
2014-12-31	zł1.95 Billion ≈ $537.74 Million	+3.34%
2013-12-31	zł1.89 Billion ≈ $520.37 Million	-1.28%
2012-12-31	zł1.92 Billion ≈ $527.12 Million	-5.40%
2011-12-31	zł2.02 Billion ≈ $557.19 Million	+28.00%
2010-12-31	zł1.58 Billion ≈ $435.30 Million	-1.44%
2009-12-31	zł1.60 Billion ≈ $441.67 Million	-22.28%
2008-12-31	zł2.06 Billion ≈ $568.26 Million	+33.54%
2007-12-31	zł1.55 Billion ≈ $425.52 Million	+55.92%
2006-12-31	zł991.63 Million ≈ $272.91 Million	+176.90%
2005-12-31	zł358.12 Million ≈ $98.56 Million	--

About Bioton S.A.

WAR:BIO Poland Biotechnology

Market Cap

$80.35 Million

zł291.94 Million PLN

Market Cap Rank

#19853 Global

#161 in Poland

Share Price

zł3.40

Change (1 day)

-2.86%

52-Week Range

zł3.40 - zł4.39

All Time High

zł15.39